Why some diabetes drugs protect the heart
Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
These diabetes drugs help the heart not by lowering bad cholesterol or blood pressure, but by helping you lose weight and better control your blood sugar.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 548 / 100
Evidence Score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
These diabetes drugs help the heart not by lowering bad cholesterol or blood pressure, but by helping you lose weight and better control your blood sugar.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 548 / 100
Evidence Score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Publication
Authors
Gomes DA, Presume J, de Araújo Gonçalves P, Almeida MS, Mendes M, Ferreira J
Related Content
Claims (6)
GLP-1 diabetes drugs help prevent heart attacks and strokes mainly by lowering blood sugar and helping people lose weight—not by lowering blood pressure or bad cholesterol.
For people with type 2 diabetes, lowering their blood sugar by 1% using certain diabetes medications is linked to a 25% lower chance of having a heart attack, stroke, or dying from heart disease.
Losing just 1 kilogram (about 2.2 pounds) of body weight while taking GLP-1 diabetes drugs is linked to a 7% lower chance of having a heart attack, stroke, or dying from heart disease.
GLP-1 diabetes drugs that lower blood sugar and weight the most tend to offer the biggest protection against heart attacks and strokes in people with type 2 diabetes.
GLP-1 receptor agonists reduce cardiovascular event rates independently of LDL cholesterol modulation, primarily through weight loss and improved metabolic health.